Publication:
The Efficacy and Drug Survival of the Biosimilar Infliximab (CT-P13) Compared to the Original Reference Infliximab in Inflammatory Rheumatic Diseases; Results from the Turkbio Registry

Simple item page
dc.contributor.authorsUslu, Sadettin; Can, Gercek; Senel, Soner; Dalkilic, Ediz; Inanc, Nevsun; Akars, Servet; Kocaer, Sinem Burcu; Birlik, Merih; Capar, Sedat; Akkoc, Nurullah; Onen, Fatos
dc.date.accessioned2022-03-10T17:57:55Z
dc.date.accessioned2026-01-11T08:26:12Z
dc.date.available2022-03-10T17:57:55Z
dc.date.issued2018
dc.identifier.doidoiWOS:000447268904265
dc.identifier.eissn2326-5205
dc.identifier.issn2326-5191
dc.identifier.urihttps://hdl.handle.net/11424/222115
dc.identifier.wosWOS:000447268904265
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofARTHRITIS & RHEUMATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleThe Efficacy and Drug Survival of the Biosimilar Infliximab (CT-P13) Compared to the Original Reference Infliximab in Inflammatory Rheumatic Diseases; Results from the Turkbio Registry
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.titleARTHRITIS & RHEUMATOLOGY
oaire.citation.volume70

Files

Collections

Araştırma Çıktıları